Skip Navigation
 

Funding


RCDC

Project Listing by Category


Back to Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC) Click the column headings to sort project listings.
  Help
12
CategoryFYFunding ICProject NumberSub Project #Project TitlePI NameOrg NameState / CountryAmount
Ovarian Cancer 2010 NCI 5R01CA103937-06 Molecular Diagnostics for Malignant Effusion SHIH, IE-MING JOHNS HOPKINS UNIVERSITY MD $338,148
Ovarian Cancer 2010 NCI 5R01CA131407-03 Re-activating Memory T Cells in the Microenvironment of Human Tumors BANKERT, RICHARD STATE UNIVERSITY OF NEW YORK AT BUFFALO NY $345,843
Ovarian Cancer 2010 NCI 5R01CA104996-06 Promoting Tumor Immunity by Cross-linking B7-DC PEASE, LARRY MAYO CLINIC MN $246,712
Ovarian Cancer 2010 NCI 5R01CA119200-04 Optical Imaging of Ovarian Carcinogenesis in a Rat Menopause Model BARTON, JENNIFER UNIVERSITY OF ARIZONA AZ $282,610
Ovarian Cancer 2010 NCI 5R01CA124630-04 PTTG Role in Ovarian Tumorigenesis and Matastasis KAKAR, SHAM UNIVERSITY OF LOUISVILLE KY $253,080
Ovarian Cancer 2010 NCI 5R01CA123249-03 Regulation of Serine Protease HtrA1 and Chemoresponse SHRIDHAR, VIJI MAYO CLINIC MN $313,533
Ovarian Cancer 2010 NCI 5R01CA114343-04 Haplotype-Based Genome Screen for Ovarian Cancer Loci SELLERS, THOMAS H. LEE MOFFITT CANCER CTR & RES INST FL $1,105,238
Ovarian Cancer 2010 NCI 5R01CA132091-03 Targeted Nanoparticle DNA Therapy for Ovarian Cancer SAWICKI, JANET LANKENAU INSTITUTE FOR MEDICAL RESEARCH PA $275,202
Ovarian Cancer 2010 NCI 5R21CA132987-02 Risk of Cancer with Incidental Findings Identified on Ultrasound Imaging SMITH-BINDMAN, REBECCA UNIVERSITY OF CALIFORNIA SAN FRANCISCO CA $172,697
Ovarian Cancer 2010 NCI 5R01CA129080-03 The Roles of HBXAP Gene in Ovarian Cancer SHIH, IE-MING JOHNS HOPKINS UNIVERSITY MD $340,300
Ovarian Cancer 2010 NICHD 5R01HD057110-03 Molecular Pathways Controlling Ovarian Gene Expression STOCCO, CARLOS UNIVERSITY OF ILLINOIS AT CHICAGO IL $300,757
Ovarian Cancer 2010 NIGMS 1SC1GM082340-01A2 The Fulvene Approach to the Syntheses of Antitumor Agents ERDEN, IHSAN SAN FRANCISCO STATE UNIVERSITY CA $268,625
Ovarian Cancer 2010 NIEHS 5R01ES005775-18 Hypoxia, Genetic Instability and DNA Mismatch Repair GLAZER, PETER YALE UNIVERSITY CT $368,271
Ovarian Cancer 2010 NCI 5R01CA120409-05 Immunotherapy of mesothelin expressing tumors with lentiviral engineered T cells JUNE, CARL UNIVERSITY OF PENNSYLVANIA PA $266,186
Ovarian Cancer 2010 NCI 1R01CA142838-01 Role of redox state in ovarian cancer response to cisplatin DANIEL, LARRY WAKE FOREST UNIVERSITY HEALTH SCIENCES NC $302,024
Ovarian Cancer 2010 NCI 1R01CA142832-01 Novel Biomarkers in Ovarian Cancer BIRRER, MICHAEL MASSACHUSETTS GENERAL HOSPITAL MA $377,561
Ovarian Cancer 2010 NCI 5R01CA079756-10 P53-Mediated G1/M Checkpoint Controls Altered by PPM1D BUCHBERG, ARTHUR THOMAS JEFFERSON UNIVERSITY PA $238,892
Ovarian Cancer 2010 NCI 5R01CA060651-18 Mouse Models to Study Gonadal Tumor Development MATZUK, MARTIN BAYLOR COLLEGE OF MEDICINE TX $266,562
Ovarian Cancer 2010 NCI 5R01CA123197-04 Death Receptor-mediated Apoptosis and Therapy Strategies in Ovarian Cancer ZHOU, TONG UNIVERSITY OF ALABAMA AT BIRMINGHAM AL $459,161
Ovarian Cancer 2010 NCI 1K07CA143047-01 Genetic Epidemiology of Ovarian and Prostate Cancer SIEH, WEIVA STANFORD UNIVERSITY CA $173,448
Ovarian Cancer 2010 NCI 5R01CA133057-02 Prognostic markers for ovarian cancer MOK, SAMUEL UNIVERSITY OF TEXAS MD ANDERSON CAN CTR TX $319,550
Ovarian Cancer 2010 NCI 5R01CA111882-05 Regulation of Adhesion and Proteolysis in Ovarian Cancer LENGYEL, ERNST UNIVERSITY OF CHICAGO IL $264,562
Ovarian Cancer 2010 NCI 1R21CA143616-01 Ovarian cancer diagnosis by monitoring immune cell bound MUC16 (CA125) PATANKAR, MANISH UNIVERSITY OF WISCONSIN MADISON WI $193,793
Ovarian Cancer 2010 NCI 1R21CA143736-01 Development of a multimarker urine-based test for early diagnosis and screening o LOKSHIN, ANNA UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $164,756
Ovarian Cancer 2010 NCI 5R21CA135130-02 Peritumorally transformable nanoparticles for intraperitoneal chemotherapy of ova YEO, YOON PURDUE UNIVERSITY WEST LAFAYETTE IN $197,922
Ovarian Cancer 2010 NCI 5R01CA085289-07 DNA Methylation and Ovarian Cancer NEPHEW, KENNETH INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS IN $241,916
Ovarian Cancer 2010 NCI 1R21CA137681-01A1 A Novel Nanocoaxial Biosensor for Detection of Cancer Biomarkers CHILES, THOMAS BOSTON COLLEGE MA $204,233
Ovarian Cancer 2010 NCI 1R15CA143701-01 Targeting MRP7 to Overcome Drug Resistance for Ovarian Cancer Therapy by Taxanes CHEN, ZHE-SHENG ST. JOHN'S UNIVERSITY NY $245,250
Ovarian Cancer 2010 NCI 9R01CA149356-09A2 The Role of MicroRNAs in Tumor Progression PETER, MARCUS UNIVERSITY OF CHICAGO IL $15,291
Ovarian Cancer 2010 NCI 2R01CA085566-06A1 Psychological Intervention for Ovarian Cancer Patients MANNE, SHARON UNIV OF MED/DENT NJ-R W JOHNSON MED SCH NJ $577,171
Ovarian Cancer 2010 NCI 9R01CA144057-06 Evaluation of Vectors based on group B adenoviruses LIEBER, ANDRE UNIVERSITY OF WASHINGTON WA $323,700
Ovarian Cancer 2010 NCI 2P01CA087969-11 7547 Ovarian Cancer TWOROGER, SHELLEY BRIGHAM AND WOMEN'S HOSPITAL MA $172,272
Ovarian Cancer 2010 NCI 2P01CA087969-11 7548 Statistical Methods ROSNER, BERNARD BRIGHAM AND WOMEN'S HOSPITAL MA $118,774
Ovarian Cancer 2010 NCI 2P01CA087969-11 7551 Biologic Specimen Management Core TWOROGER, SHELLEY BRIGHAM AND WOMEN'S HOSPITAL MA $488,774
Ovarian Cancer 2010 NCI 5R01CA095175-07 Analysis of BRCA1 recombination functions SCULLY, RALPH BETH ISRAEL DEACONESS MEDICAL CENTER MA $304,354
Ovarian Cancer 2010 NCI 5R01CA123219-03 The Role of Aberrant Splicing of EVl1 in Ovarian Cancer Pathophysiology MILLS, GORDON UNIVERSITY OF TEXAS MD ANDERSON CAN CTR TX $314,578
Ovarian Cancer 2010 NCI 5R01CA116674-05 Epigenetic regulation of cancer/germ-line antigen gene expression KARPF, ADAM ROSWELL PARK CANCER INSTITUTE CORP NY $282,184
Ovarian Cancer 2010 NCI 5R01CA109298-06 Ovarian Cancer: Mechanisms of Neuroendocrine Regulation SOOD, ANIL UNIVERSITY OF TEXAS MD ANDERSON CAN CTR TX $358,839
Ovarian Cancer 2010 NCI 5R01CA051578-18 A POLYMERIC DRUG DELIVERY SYSTEM FOR CANCER THERAPY KOPECEK, JINDRICH UNIVERSITY OF UTAH UT $236,153
Ovarian Cancer 2010 NCI 5R01CA136891-02 A Pooled Analysis to Identify New Ovarian Cancer Risk Factors PEARCE, CELESTE UNIVERSITY OF SOUTHERN CALIFORNIA CA $333,819
Ovarian Cancer 2010 NCI 5F32CA138153-02 Multimodality Microendoscope for Metastatic Ovarian Cancer Detection & Treatment EVANS, CONOR MASSACHUSETTS GENERAL HOSPITAL MA $50,474
Ovarian Cancer 2010 NCI 1R43CA141742-01A1 Targeted Radiotherapy of Ovarian Cancer with a Novel, High Payload Radioligand SANDS, HOWARD SOLIXIA, INC. PA $161,098
Ovarian Cancer 2010 NCI 5R01CA101850-06 ENGINEERED INTELLIGENT MICELLE FOR TUMOR pH TARGETING BAE, YOU UNIVERSITY OF UTAH UT $271,181
Ovarian Cancer 2010 NCI 5R01CA116984-05 G Proteins and Their Receptors in Tumor Cell Metastasis DHANASEKARAN, DANNY UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR OK $300,580
Ovarian Cancer 2010 NCI 1R44CA144586-01 IHC Test for BRCA1 Hereditary Ovarian Cancer HOLT, JEFFREY TISSUE GENETICS, INC. CO $163,634
Ovarian Cancer 2010 NCI 1F32CA144389-01 Transcription, Choice and the 3D Architecture of the Inactive X-Chromosome MUGFORD, JOSHUA UNIVERSITY OF NORTH CAROLINA CHAPEL HILL NC $47,606
Ovarian Cancer 2010 NCI 1R43CA144591-01 EGFR-Targeted Nanoemulsions for Imaging and Therapy of Ovarian Cancer COLEMAN, TIMOTHY NEMUCORE MEDICAL INNOVATIONS, INC. MA $149,855
Ovarian Cancer 2010 NCI 5R01CA124515-04 Vascular Leukocytes influence the tumor microenvironment CONEJO-GARCIA, JOSE DARTMOUTH COLLEGE NH $303,810
Ovarian Cancer 2010 NCI 5R01CA138762-02 Splicing factors as therapeutic targets for the treatment of ovarian cancer BECK, WILLIAM UNIVERSITY OF ILLINOIS AT CHICAGO IL $313,715
Ovarian Cancer 2010 NCI 7R01CA139159-02 Signal Transduction Enzyme Inhibitors from Extremophilic Microbes as Anticancer A STIERLE, ANDREA UNIVERSITY OF MONTANA MT $215,936
Ovarian Cancer 2010 NCI 1F32CA144898-01 Role of Tumor Microenvironment in Ovarian Cancer Progression THOMPSON, MELISSA UNIVERSITY OF TEXAS MD ANDERSON CAN CTR TX $48,206
Ovarian Cancer 2010 NCI 5R01CA131183-03 RAS Signaling, Senescent Fibroblasts, and Ovarian Cancer Progression LIU, JINSONG UNIVERSITY OF TEXAS MD ANDERSON CAN CTR TX $255,640
Ovarian Cancer 2010 NCI 5R01CA133117-02 Role of the Mullerian Tract in Ovarian Cancer Development DUBEAU, LOUIS UNIVERSITY OF SOUTHERN CALIFORNIA CA $336,841
Ovarian Cancer 2010 NCI 5R01CA136549-02 Regulation of the ATM/ATR-p53 DNA Damage Signaling Pathway by the Wip1 Phosphatas LU, XIONGBIN UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA SC $298,800
Ovarian Cancer 2010 NCI 5R01CA136491-02 Development of an Assay for the Early Detection of Ovarian Cancer BRARD, LAURENT WOMEN AND INFANTS HOSPITAL-RHODE ISLAND RI $430,401
Ovarian Cancer 2010 NCI 5R01CA112523-05 Steroid Hormone Genes and Ovarian Cancer Risk ROSSING, MARY FRED HUTCHINSON CANCER RESEARCH CENTER WA $464,332
Ovarian Cancer 2010 NCI 5R01CA130911-03 Chimeric NKG2D receptors in ovarian cancer immunotherapy SENTMAN, CHARLES DARTMOUTH COLLEGE NH $331,793
Ovarian Cancer 2010 NCI 5R01CA131200-02 Regulation of Ovarian Cancer Multidrug Resistance by MAP Kinases EBLEN, SCOTT MEDICAL UNIVERSITY OF SOUTH CAROLINA SC $305,274
Ovarian Cancer 2010 NCI 5R01CA122728-03 Treatment of Chemotherapy-Resistant Human Ovarian Cancer by Administration of CPE SANTIN, ALESSANDRO YALE UNIVERSITY CT $344,171
Ovarian Cancer 2010 NCI 5R01CA114037-04 Taxane Resistance in Breast and Ovarian Cancer Cells SIKIC, BRANIMIR STANFORD UNIVERSITY CA $297,730
Ovarian Cancer 2010 NCI 5R01CA136494-02 Molecular mechanism of antiangiogenic properties of gold nanoparticle MUKHERJEE, PRIYABRATA MAYO CLINIC MN $282,179
Ovarian Cancer 2010 NCI 5R01CA131965-02 Defining a Pre-Malignant Phenotype in Fallopian Tube Epithelium SWISHER, ELIZABETH UNIVERSITY OF WASHINGTON WA $323,700
Ovarian Cancer 2010 NCI 5K08CA106597-05 Chromatin structure and BRCA1 Checkpoint Function GREENBERG, ROGER UNIVERSITY OF PENNSYLVANIA PA $135,677
Ovarian Cancer 2010 NCI 5R01CA086061-10 Mechanistic Comparison of Cisplatin with Synthetic DNA Repair-Shielding Anticance ESSIGMANN, JOHN MASSACHUSETTS INSTITUTE OF TECHNOLOGY MA $282,619
Ovarian Cancer 2010 NCI 5R01CA136547-02 Optimizing Measles Virotherapy in the Treatment of Ovarian Cancer GALANIS, EVANTHIA MAYO CLINIC MN $530,593
Ovarian Cancer 2010 NCI 5R01CA123088-04 Novel immunosupressive macrophages in human ovarian tumor ZOU, WEIPING UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $288,800
Ovarian Cancer 2010 NCI 5R01CA135312-03 Dendritic nanomedicine for cancer imaging and treatment TUNG, CHING-HSUAN METHODIST HOSPITAL RESEARCH INSTITUTE TX $311,250
Ovarian Cancer 2010 NCI 5R01CA095071-09 Epithelial Positioning Organization and Ovarian Cancer XU, XIANGXI MIKE UNIVERSITY OF MIAMI SCHOOL OF MEDICINE FL $323,942
Ovarian Cancer 2010 NCI 5R01CA120429-04 Regulation of MDR1 Expression and Drug Resistance by CD44 RODRIGUEZ-RODRIGUEZ, LORNA UNIV OF MED/DENT NJ-R W JOHNSON MED SCH NJ $296,400
Ovarian Cancer 2010 NCI 5R01CA125636-04 The Fanconi Anemia-BRCA Pathway And Chemosensitivity of Human Cancer TANIGUCHI, TOSHIYASU FRED HUTCHINSON CANCER RESEARCH CENTER WA $320,565
Ovarian Cancer 2010 NCI 5R01CA121187-04 Monitoring of advanced virotherapy for ovarian cancer CURIEL, DAVID UNIVERSITY OF ALABAMA AT BIRMINGHAM AL $275,500
Ovarian Cancer 2010 NCI 5R01CA135179-02 INTERNET DECISION SUPPORT FOR BRCA1/BRCA2 CARRIERS SCHWARTZ, MARC GEORGETOWN UNIVERSITY DC $438,917
Ovarian Cancer 2010 NCI 5R01CA137041-02 MicroRNAs in Human Ovarian Cancer CHENG, JIN H. LEE MOFFITT CANCER CTR & RES INST FL $346,525
Ovarian Cancer 2010 NCI 5R01CA127913-03 MyD88-bearing tumors in immune-regulation and chemo-resistance MOR, GIL YALE UNIVERSITY CT $343,413
Ovarian Cancer 2010 NCI 5R01CA134424-02 A Spatial-Spectral Volume Holographic Imaging System for Ex-Vivo and In-Vivo Canc KOSTUK, RAYMOND UNIVERSITY OF ARIZONA AZ $420,959
Ovarian Cancer 2010 NCI 5R21CA137686-02 High-throughput intracellular microrheology: a new tool for cancer research WIRTZ, DENIS JOHNS HOPKINS UNIVERSITY MD $243,480
Ovarian Cancer 2010 NCI 5R01CA138556-02 Impact of exercise on ovarian cancer prognosis IRWIN, MELINDA YALE UNIVERSITY CT $668,926
Ovarian Cancer 2010 NCI 5R01CA094172-09 Molecular Pathogenesis of Ovarian Endometrioid Adenocarcinomas CHO, KATHLEEN UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $261,178
Ovarian Cancer 2010 NCI 1R01CA149429-01 The Mitochondrial Genome and Ovarian Cancer Risk PHELAN, CATHERINE H. LEE MOFFITT CANCER CTR & RES INST FL $728,415
Ovarian Cancer 2010 NCI 5R01CA126841-02 Regulatory T Cell Function in Ovarian Cancer MOYSICH, KIRSTEN ROSWELL PARK CANCER INSTITUTE CORP NY $629,546
Ovarian Cancer 2010 NCI 1K08CA148887-01 Targeting Histone Deacetylases with Small Moleule Inhibitors in Ovarian Cancer KHABELE, DINEO VANDERBILT UNIVERSITY TN $159,084
Ovarian Cancer 2010 NCI 2U10CA027469-30 Gynecologic Oncology Group DISAIA, PHILIP GYNECOLOGIC ONCOLOGY GROUP MD $8,224,605
Ovarian Cancer 2010 NCI 1R21CA150237-01 Targeting lipid metabolic and signaling enzyme in ovarian cancer NG, SHU-WING BRIGHAM AND WOMEN'S HOSPITAL MA $217,918
Ovarian Cancer 2010 NCI 5R03CA142074-02 Prevention of Menopause-Related Ovarian Epithelial Cancer SMITH, ELIZABETH UNIVERSITY OF MIAMI SCHOOL OF MEDICINE FL $76,500
Ovarian Cancer 2010 NCI 2U54CA113001-06 Interrogating Epigenetic Changes in Cancer Genomes HUANG, TIM OHIO STATE UNIVERSITY OH $1,596,781
Ovarian Cancer 2010 NCI 5R43CA135960-02 Portable photonic sensor system as an early detection tool for ovarian cancer WAWRO, DEBRA RESONANT SENSORS INC. TX $89,216
Ovarian Cancer 2010 NCI 5R01CA131400-02 VALIDATING AND TARGETING LYSOPHOSPHATIDIC ACID ACYLTRANSFERASE-BETA IN CANCER SPRINGETT, GREGORY H. LEE MOFFITT CANCER CTR & RES INST FL $346,525
Ovarian Cancer 2010 NCI 5R01CA092520-10 Tumor Host Range Mutants of Polyoma and Their Targets BENJAMIN, THOMAS HARVARD UNIVERSITY (MEDICAL SCHOOL) MA $646,176
Ovarian Cancer 2010 NCI 5K24CA087933-10 Clinical Investigator Development in Solid Tumor Oncology SPRIGGS, DAVID SLOAN-KETTERING INSTITUTE FOR CANCER RES NY $153,090
Ovarian Cancer 2010 NIGMS 5R01GM088055-11 Structural and Functional Characterization of BRCA1/BARD1 KLEVIT, RACHEL UNIVERSITY OF WASHINGTON WA $374,448
Ovarian Cancer 2010 NCI 5R01CA116779-05 Vascular Leukocytes Induce regulatory T cells (Treg) in Tumors COUKOS, GEORGE UNIVERSITY OF PENNSYLVANIA PA $271,456
Ovarian Cancer 2010 NCI 5R01CA136512-02 BRCA1 Function in Post-Damage Nuclear Foci LIVINGSTON, DAVID DANA-FARBER CANCER INSTITUTE MA $525,558
Ovarian Cancer 2010 NCI 2R01CA086984-11 Regulation of Ovarian Carcinoma Proteinases STACK, MARY UNIVERSITY OF MISSOURI-COLUMBIA MO $301,599
Ovarian Cancer 2010 NCI 2R01CA099985-04 Human Tregs in Ovarian Cancer ZOU, WEIPING UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $223,679
Ovarian Cancer 2010 NCI 2R01CA031841-30 Synthetic Studies on Tumor Promoters and Inhibitors WENDER, PAUL STANFORD UNIVERSITY CA $328,087
Ovarian Cancer 2010 NCI 5R01CA132630-04 Chemical Probes for Metabolic Pathway Discovery in Human Disease CRAVATT, BENJAMIN SCRIPPS RESEARCH INSTITUTE CA $439,287
Ovarian Cancer 2010 NCI 1R01CA140323-01A1 Exploiting Biological Networks to Improve Clinical Treatment of Ovarian Cancer GODWIN, ANDREW FOX CHASE CANCER CENTER PA $423,060
Ovarian Cancer 2010 NCI 1R01CA141078-01A1 Multifunctional roles of homeobox gene DLX4 in ovarian cancer NAORA, HONAMI UNIVERSITY OF TEXAS MD ANDERSON CAN CTR TX $327,850
Ovarian Cancer 2010 NCI 2R01CA115483-06 Therapeutic Targeting Agents for Ovarian Cancer LAM, KIT UNIVERSITY OF CALIFORNIA DAVIS CA $302,871
Ovarian Cancer 2010 NCI 2R01CA108970-06 CD4+ Memory T-Cells in Human Tumor Microenvironment BANKERT, RICHARD STATE UNIVERSITY OF NEW YORK AT BUFFALO NY $323,034
Ovarian Cancer 2010 NINR 5R01NR010735-03 Web-Based Ovarian Cancer Symptom Control: Nurse-Guided vs. Self-Directed DONOVAN, HEIDI UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $565,708
Ovarian Cancer 2010 NCI 5R01CA135006-02 Role of TbRIII in Regulating Motility and Invasion BLOBE, GERARD DUKE UNIVERSITY NC $441,531
Ovarian Cancer 2010 NCI 5R01CA140933-02 Biobehavioral Influences and the Ovarian Tumor Microenvironment LUTGENDORF, SUSAN UNIVERSITY OF IOWA IA $558,863
Ovarian Cancer 2010 NCI 5R01CA092889-09 Role of TGFbeta in Microtubule Dynamics MULDER, KATHLEEN PENNSYLVANIA STATE UNIV HERSHEY MED CTR PA $269,269
Ovarian Cancer 2010 NCI 5R01CA127562-04 Development of PEA 15 as a Targeted Therapeutic Gene for Ovarian Cancer UENO, NAOTO UNIVERSITY OF TEXAS MD ANDERSON CAN CTR TX $292,600
Ovarian Cancer 2010 NCI 5R01CA118678-04 Apoptotic regulators in ovarian cancer MOR, GIL YALE UNIVERSITY CT $314,450
Ovarian Cancer 2010 NICHD 1K99HD059985-01A2 GPR30 Mediated-Estrogen Action on Ovarian Physiology and Ovarian Cancer WANG, CHENG UNIVERSITY OF NEBRASKA MEDICAL CENTER NE $90,000
Ovarian Cancer 2010 NCI 1R03CA150039-01 MITOCHONDRIAL GENOME ANALYSIS OF EPITHELIAL SEROUS OVARIAN CARCINOMA AIKHIONBARE, FELIX MOREHOUSE SCHOOL OF MEDICINE GA $58,000
Ovarian Cancer 2010 NCI 5R01CA122581-05 Tumor-Associated Antigens in Early Stage Serous Carcinoma RODEN, RICHARD JOHNS HOPKINS UNIVERSITY MD $263,559
Ovarian Cancer 2010 NCI 5R01CA122443-04 Genetic Variation in the NF-kappaB Pathway and Ovarian Cancer Etiology GOODE, ELLEN MAYO CLINIC MN $492,570
Ovarian Cancer 2010 NCI 5R44CA123785-03 Fast-Track:Biomagnetic In-vivo Imaging of Ovarian Cancer FLYNN, EDWARD SENIOR SCIENTIFIC NM $362,274
Ovarian Cancer 2010 NCI 7R01CA095319-08 Novel Fas/CD95 Signaling Mechanisms PETER, MARCUS NORTHWESTERN UNIVERSITY IL $273,024
Ovarian Cancer 2010 NCI 5K25CA120350-04 A near-infrared contrast agent for targeted imaging of cancer ROMANOWSKI, MAREK UNIVERSITY OF ARIZONA AZ $141,776
Ovarian Cancer 2010 NCI 5K25CA128666-04 Comparative Proteomics Applied to the Avian Model of Ovarian Cancer HAWKRIDGE, ADAM NORTH CAROLINA STATE UNIVERSITY RALEIGH NC $143,370
Ovarian Cancer 2010 NCI 5R01CA075334-13 MRI studies of angiogenesis in ovarian cancer NEEMAN, MICHAL WEIZMANN INSTITUTE OF SCIENCE ISRAEL $102,771
Ovarian Cancer 2010 NCI 5R01CA118158-05 The role of BRCA1 in nonhomologous repair of chromosomal double-strand breaks XIA, FEN VANDERBILT UNIVERSITY TN $238,105
Ovarian Cancer 2010 NCI 5R21CA132026-02 Boosting anti-tumor immune responses by modulating genes with nanoparticles CONEJO-GARCIA, JOSE DARTMOUTH COLLEGE NH $205,073
Ovarian Cancer 2010 NCI 5R01CA118578-06 The Mechanism of BRCA1 in Tumor Suppression HU, YANFEN UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT TX $201,308
Ovarian Cancer 2010 NCI 5R01CA120061-06 Hormone levels during pregnancy and maternal ovarian cancer LUKANOVA, ANNEKATRIN GERMAN CANCER RESEARCH CENTER GERM $379,595
Ovarian Cancer 2010 NHGRI 5R01HG005055-03 INTERNET INTERVENTION FOR BRCA1/BRCA2 UNINFORMATIVES SCHWARTZ, MARC GEORGETOWN UNIVERSITY DC $555,028
Ovarian Cancer 2010 NCI 5R33CA122904-04 Identification of T Cell-Defined Antigens in Ovarian Cancer YEE, CASSIAN FRED HUTCHINSON CANCER RESEARCH CENTER WA $391,253
Ovarian Cancer 2010 NCI 5R01CA058598-12 Collaborative Genetic Study of Ovarian Cancer Risk GOODMAN, MARC UNIVERSITY OF HAWAII AT MANOA HI $534,918
Ovarian Cancer 2010 NHLBI 1R43HL099217-01A1 ChNKG2D-Targeted Cellular Cancer Therapy: Preclinical Toxicology SENTMAN, CARIN CELDARA MEDICAL, LLC NH $413,428
Ovarian Cancer 2010 NCI 1R43CA154339-01 Magnetic Nanoparticles and Quantum Dots for Diagnosis of Early Stage Ovarian Canc AGUILAR, ZORAIDA OCEAN NANOTECH, LLC AR $150,075
Ovarian Cancer 2010 NICHD 5K12HD055881-04 VCU Building Interdisciplinary Research Careers in Women's Health STRAUSS, JEROME VIRGINIA COMMONWEALTH UNIVERSITY VA $50,000
Ovarian Cancer 2010 OD 5K12HD055881-04 VCU Building Interdisciplinary Research Careers in Women's Health STRAUSS, JEROME VIRGINIA COMMONWEALTH UNIVERSITY VA $446,801
Ovarian Cancer 2010 NCI 5R01CA129142-02 Bridging Geographic Barriers: Remote Cancer Genetics Counseling for Rural Women KINNEY, ANITA UNIVERSITY OF UTAH UT $609,137
Ovarian Cancer 2010 NCI 1R13CA139632-01A1 Joining FORCEs Against Hereditary Cancer: Annual Conference on Hereditary Breast LARONGA, CHRISTINE H. LEE MOFFITT CANCER CTR & RES INST FL $8,000
Ovarian Cancer 2010 NCI 5R01CA136596-02 The Role of HEF1 in Ovarian Cancer Development, Progression, and Metastasis CONNOLLY, DENISE FOX CHASE CANCER CENTER PA $325,879
Ovarian Cancer 2010 NCI 5K07CA131094-03 Epigentics and Female Reproductive Cancers PERRIN, MARY NEW YORK UNIVERSITY SCHOOL OF MEDICINE NY $139,320
Ovarian Cancer 2010 NCI 1R03CA139905-01A2 Sociocultural Factors and BRCA Genetic Counseling for Diverse Latinas SUSSNER, KATARINA MOUNT SINAI SCHOOL OF MEDICINE NY $83,986
Ovarian Cancer 2010 NCI 1R01CA142081-01A1 Epidemiology of Ovarian Cancer in African-American Women SCHILDKRAUT, JOELLEN DUKE UNIVERSITY NC $2,191,541
Ovarian Cancer 2010 NCI 5K07CA108987-05 Clinical Relevance of Mismatch Repair in Ovarian Cancer PAL, TUYA H. LEE MOFFITT CANCER CTR & RES INST FL $132,823
Ovarian Cancer 2010 NCI 5R01CA134487-03 Mesothelin as biomarker and therapeutic target HELLSTROM, INGEGERD UNIVERSITY OF WASHINGTON WA $270,000
Ovarian Cancer 2010 NCI 5K25CA111636-07 Clinico-Genomics for Improved Ovarian Cancer Treatment CLARKE, JENNIFER UNIVERSITY OF MIAMI SCHOOL OF MEDICINE FL $60,119
Ovarian Cancer 2010 NCI 5K99CA134750-02 The Role of the Microenvironment in Early Ovarian Cancer Metastasis KENNY, HILARY UNIVERSITY OF CHICAGO IL $111,389
Ovarian Cancer 2010 NCI 5R33CA110499-04 Molecular Profiling to Predict Response to Chemotherapy LANCASTER, JOHNATHAN H. LEE MOFFITT CANCER CTR & RES INST FL $276,313
Ovarian Cancer 2010 NCI 5R42CA124191-03 BRCA2 Hereditary Ovarian Cancer Tissue Truncation Test HOLT, JEFFREY TISSUE GENETICS, INC. CO $307,776
Ovarian Cancer 2010 NCI 5R01CA127239-03 pBACH1 binding site on BRCT(BRCA1): A novel approach to cancer therapeutics NATARAJAN, AMARNATH UNIVERSITY OF NEBRASKA MEDICAL CENTER NE $278,966
Ovarian Cancer 2010 NCI 5R21CA141241-02 Development and Pilot Test of an Elective BSO Decision Support Guide KUPPERMANN, MIRIAM UNIVERSITY OF CALIFORNIA SAN FRANCISCO CA $169,950
Ovarian Cancer 2010 NCI 1U19CA148112-01 8865 Follow-up of Ovarian Cancer Genetic Association and Interaction Studies (FOCI) SELLERS, THOMAS H. LEE MOFFITT CANCER CTR & RES INST FL $618,841
Ovarian Cancer 2010 NCI 1U19CA148112-01 8866 Ovarian cancer GWAS discovery, expansion and replication (N2 - Project #1) SELLERS, THOMAS H. LEE MOFFITT CANCER CTR & RES INST FL $986,904
Ovarian Cancer 2010 NCI 1U19CA148112-01 8867 Functional assessment of genes and common genetic risk variants in ovarian cancer SELLERS, THOMAS H. LEE MOFFITT CANCER CTR & RES INST FL $583,252
Ovarian Cancer 2010 NCI 1U19CA148112-01 8868 Genetic and environmental interaction analyses and risk prediction modeling SELLERS, THOMAS H. LEE MOFFITT CANCER CTR & RES INST FL $592,661
Ovarian Cancer 2010 NCI 5R01CA083855-11 Prophytactic surgery in carriers of BRCA 1/2 mutations REBBECK, TIMOTHY UNIVERSITY OF PENNSYLVANIA PA $709,500
Ovarian Cancer 2010 NCI 5R01CA118846-04 Regulation of gene silencing by exogenous sphingosine SCHMELZ, EVA VIRGINIA POLYTECHNIC INST AND ST UNIV VA $271,035
Ovarian Cancer 2010 NIAID 5SC1AI089073-02 Roles of inflammation-driven chemokines in the pathogenesis of ovarian cancer SON, DEOK-SOO MEHARRY MEDICAL COLLEGE TN $362,588
Ovarian Cancer 2010 NCI 5R03CA139492-02 Ovulation, inclusion cysts, and p53 mutations in a mouse model of ovarian cancer BURDETTE, JOANNA UNIVERSITY OF ILLINOIS AT CHICAGO IL $78,500
Ovarian Cancer 2010 NCI 5SC2CA150317-02 Role of Mitochondrial Genomic Alterations in Epithelial Ovarian Tumors AIKHIONBARE, FELIX MOREHOUSE SCHOOL OF MEDICINE GA $140,000
Ovarian Cancer 2010 NCI 1R01CA151374-01 Evaluation of In Vivo Optical Imaging in Pancreatic and Ovarian Cancer Patients MARTIN, LAINIE FOX CHASE CANCER CENTER PA $407,574
Ovarian Cancer 2010 NCI 2P50CA083639-11 7762 P1 - Early Detection of Epithelial Ovarian Cancer BAST, ROBERT UNIVERSITY OF TEXAS MD ANDERSON CAN CTR TX $917,914
Ovarian Cancer 2010 NCI 2P50CA083639-11 7764 P2 - Targeting DII4-Notch Signaling in Ovarian Cancer SOOD, ANIL UNIVERSITY OF TEXAS MD ANDERSON CAN CTR TX $199,352
Ovarian Cancer 2010 NCI 2P50CA083639-11 7767 P3 - Personalized Therapy for Low-Grade Serous Carcinoma of the Ovary GERSHENSON, DAVID UNIVERSITY OF TEXAS $200,426
Ovarian Cancer 2010 NCI 2P50CA083639-11 7768 P4 - Pers. Therapy for High-Grade Ovarian Cancer: Targeting PI3Kness & BRCAne MILLS, GORDON UNIVERSITY OF TEXAS MD ANDERSON CAN CTR TX $180,145
Ovarian Cancer 2010 NCI 2P50CA083639-11 7770 P5 - Gene-modified MSCs for Controlling Ovarian Cancer MARINI, FRANK UNIVERSITY OF TEXAS MD ANDERSON CAN CTR TX $179,800
Ovarian Cancer 2010 NCI 2P50CA083639-11 7771 Administrative Core GERSHENSON, DAVID UNIVERSITY OF TEXAS MD ANDERSON CAN CTR TX $25,172
Ovarian Cancer 2010 NCI 2P50CA083639-11 7772 Biostatistics, Bioinformatics and Systems Biology (BBSB) Core ATKINSON, E UNIVERSITY OF TEXAS MD ANDERSON CAN CTR TX $276,498
Ovarian Cancer 2010 NCI 2P50CA083639-11 7773 Pathology Core BROADDUS, RUSSELL UNIVERSITY OF TEXAS MD ANDERSON CAN CTR TX $117,295
Ovarian Cancer 2010 NCI 2P50CA083639-11 7774 Developmental Research Program GERSHENSON, DAVID UNIVERSITY OF TEXAS MD ANDERSON CAN CTR TX $80,910
Ovarian Cancer 2010 NCI 2P50CA083639-11 7775 Career Developmental Program GERSHENSON, DAVID UNIVERSITY OF TEXAS MD ANDERSON CAN CTR TX $53,940
Ovarian Cancer 2010 NCI 1U01CA151461-01 Tumor Targeted Nanobins for the Treatment of Metastatic Breast and Ovarian Cancer O'HALLORAN, THOMAS NORTHWESTERN UNIVERSITY IL $461,174
Ovarian Cancer 2010 NCI 1U01CA151648-01 RNA Nanotechnology in Cancer Therapy GUO, PEIXUAN UNIVERSITY OF CINCINNATI OH $485,825
Ovarian Cancer 2010 NCI 5F32CA142117-02 Modulation of tumor-associated macrophage phenotype by S1P receptors BLAHO, VICTORIA WEILL MEDICAL COLLEGE OF CORNELL UNIV NY $52,154
Ovarian Cancer 2010 NICHD 1R15HD066302-01 Receptor/Ligand Signals for Ovarian Follicular Angiogenesis SPICER, LEON OKLAHOMA STATE UNIVERSITY STILLWATER OK $352,346
Ovarian Cancer 2010 RMAP 1DP2OD007096-01 Imaging and Overcoming Hypoxia-Induced Resistance in Metastatic Ovarian Cancer EVANS, CONOR MASSACHUSETTS GENERAL HOSPITAL MA $2,655,000
Ovarian Cancer 2010 RMAP 1DP2OD007391-01 ULTRASENSITIVE NANOLASERS FOR EPIGENETICS INVESTIGATIONS ARMANI, ANDREA UNIVERSITY OF SOUTHERN CALIFORNIA CA $2,430,000
Ovarian Cancer 2010 NCI 1U01CA152637-01 Breast and Ovary Cancer Clinical Validation Center LI, CHRISTOPHER FRED HUTCHINSON CANCER RESEARCH CENTER WA $859,566
Ovarian Cancer 2010 NCI 1U54CA151662-01 8772 Magnetic nanoparticle Immunotherapy against Ovarian Cancer CONEJO-GARCIA, JOSE DARTMOUTH COLLEGE NH $244,217
Ovarian Cancer 2010 NCI 1U54CA151662-01 8775 Toxicology, Pathology and Biodistribution Core (TPB Core) LEWIS, LIONEL DARTMOUTH COLLEGE NH $95,876
Ovarian Cancer 2010 NCI 2U01CA084955-11 Atlantic Breast and Gynecologic Clinical Validation Center MARKS, JEFFREY DUKE UNIVERSITY NC $513,677
Ovarian Cancer 2010 NCI 1U01CA152755-01 An integrated systems biology approach for ovarian cancer biomarker discovery DIAMANDIS, ELEFTHERIOS MT SINAI HOSP-SAMUEL LUNENFELD RES INST CANADA $301,643
Ovarian Cancer 2010 NCI 1U54CA151668-01 8844 Multistage Vectors (MSV) for Ovarian Cancer Therapeutics LOPEZ-BERESTEIN, GABRIEL UNIVERSITY OF TEXAS MD ANDERSON CAN CTR TX $744,984
Ovarian Cancer 2010 NCI 1U54CA151668-01 8845 Nanotechnology Platforms for Targeting Ovarian Cancer Vasculature SOOD, ANIL UNIVERSITY OF TEXAS MD ANDERSON CAN CTR TX $339,218
Ovarian Cancer 2010 NCI 1U54CA151668-01 8847 Multifunctional Nanoassemblies for Ligand-directed Imaging and Therapy of Endocri ARAP, WADIH UNIVERSITY OF TEXAS MD ANDERSON CAN CTR TX $306,459
Ovarian Cancer 2010 NCI 1U54CA151459-01 8855 Next Generation Smart Nanoparticles ALIVISATOS, PAUL UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB CA $1,099,581
Ovarian Cancer 2010 NCI 1U54CA151459-01 8856 Magneto-Nano Diagnostic and Analytical Devices for Cancer WANG, SHAN STANFORD UNIVERSITY CA $292,060
Ovarian Cancer 2010 NCI 1U54CA151459-01 8858 Integration of Nano-Molecular Imaging and Nanosensors GAMBHIR, SANJIV STANFORD UNIVERSITY CA $193,500
Ovarian Cancer 2010 NCI 1U54CA151459-01 8865 Pilot Projects GAMBHIR, SANJIV STANFORD UNIVERSITY CA $60,200
Ovarian Cancer 2010 NCI 5F31CA144083-02 Defining double-stranded RNA receptor induced apoptosis in ovarian cancer. SCHRAMM, DANIELLE VIRGINIA COMMONWEALTH UNIVERSITY VA $32,470
Ovarian Cancer 2010 NCI 1U54CA151819-01 8878 Organ-specific, Blood Protein Biomarkers for an Informative Diagnosis of Brain an HOOD, LEROY INSTITUTE FOR SYSTEMS BIOLOGY WA $761,694
Ovarian Cancer 2010 NCI 1U54CA151819-01 8879 Novel Nanotechnologies and Molecular Imaging Approaches for Cancer Immunotherapy RADU, CAIUS UNIVERSITY OF CALIFORNIA LOS ANGELES CA $381,654
Ovarian Cancer 2010 NCI 1U54CA151819-01 8883 Administrative Core HEATH, JAMES CALIFORNIA INSTITUTE OF TECHNOLOGY CA $116,136
Ovarian Cancer 2010 NCI 1U54CA151884-01 5023 Nanoformulations for siRNA Delivery to Ovarian Cancer SHARP, PHILLIP MASSACHUSETTS INSTITUTE OF TECHNOLOGY MA $269,012
Ovarian Cancer 2010 NCI 1U54CA151881-01 5122 Combination Anticancer Nanopreparations of Novel Proapoptotic Drug and siRNA TORCHILIN, VLADIMIR NORTHEASTERN UNIVERSITY MA $853,888
Ovarian Cancer 2010 NCI 1U54CA151881-01 5124 Combination Nanotherapeutic Strategies to Overcome Tumor Drug Resistance MINKO, TAMARA RUTGERS THE STATE UNIVERSITY OF NJ NJ $290,904
Ovarian Cancer 2010 NCI 2R01CA115780-05A1 Diagnosis of Ovarian Cancer by Confocal Microendoscopy GMITRO, ARTHUR UNIVERSITY OF ARIZONA AZ $285,016
Ovarian Cancer 2010 NCI 1R01CA138628-01A2 Role of the BMP SMADs in Oncogenesis PANGAS, STEPHANIE BAYLOR COLLEGE OF MEDICINE TX $162,369
Ovarian Cancer 2010 NCI 1R01CA149260-01A1 Improving the Efficacy of Cisplatin-Based Cancer Chemotherapy KUO, MACUS UNIVERSITY OF TEXAS MD ANDERSON CAN CTR TX $327,850
Ovarian Cancer 2010 NCI 7R01CA123233-03 Regulation of JNK-signaling molecules by the gep oncogenes DHANASEKARAN, DANNY UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR OK $248,751
Ovarian Cancer 2010 NCI 1R01CA138533-01A1 Multifunctional Nanotherapeutics for Cancer Treatment and Imaging MINKO, TAMARA RUTGERS THE ST UNIV OF NJ NEW BRUNSWICK NJ $329,466
Ovarian Cancer 2010 NIBIB 1R01EB011523-01A1 Image-Guided Surgery of Endocrine Glands and Their Tumors using Near-Infrared Flu CHOI, HAK SOO BETH ISRAEL DEACONESS MEDICAL CENTER MA $513,850
Ovarian Cancer 2010 NCI 2R01CA108990-06 Urine and Serum Biomarkers for Screening and Diagnosis of Ovarian Cancer LOKSHIN, ANNA UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $322,540
Ovarian Cancer 2010 NCI 1R01CA142783-01A1 Signaling in the ovarian cancer metastatic microenvironment SLACK-DAVIS, JILL UNIVERSITY OF VIRGINIA CHARLOTTESVILLE VA $313,652
Ovarian Cancer 2010 NCI 1R01CA141154-01A2 Identifying Ovarian Cancer Susceptibility Alleles using Genome-Wide Scan Data PEARCE, CELESTE UNIVERSITY OF SOUTHERN CALIFORNIA CA $716,356
Ovarian Cancer 2010 NCI 1K22CA138563-01A2 Obesity in ovarian cancer prognosis BANDERA, ELISA UNIV OF MED/DENT NJ-R W JOHNSON MED SCH NJ $203,040
Ovarian Cancer 2010 NCI 1U01CA152990-01 Proteomic, Genetic & Longitudinal Pathways to Ovarian Cancer Biomarker Discovery SKATES, STEVEN MASSACHUSETTS GENERAL HOSPITAL MA $711,452
Ovarian Cancer 2010 OD 1R03CA141318-01A1 Nuclear Pore Complex Architecture and Drug Resistance in Ovarian Carcinomas KOHTZ, DONALD MOUNT SINAI SCHOOL OF MEDICINE NY $84,750
Ovarian Cancer 2010 NICHD 1R03HD058909-01A2 Regulation of Fetal Ovarian Development by GATA4 BOUMA, GERRIT COLORADO STATE UNIVERSITY-FORT COLLINS CO $73,500
Ovarian Cancer 2010 NCI 1R01CA148747-01A1 Targeting the Mullerian Inhibiting Substance pathway in gynecologic cancer CLIBY, WILLIAM MAYO CLINIC MN $163,614
Ovarian Cancer 2010 NCI 2R01CA099471-06A2 Gonadotropins & Cox-2 in Ovarian Cancer Prevention XU, XIANGXI MIKE UNIVERSITY OF MIAMI SCHOOL OF MEDICINE FL $400,502
Ovarian Cancer 2010 NINR 1F31NR012341-01 Prophylactic, risk-reducing surgery in BRCA-positive women: sexual functioning a TOLLIN, SHARON UNIVERSITY OF SOUTH FLORIDA FL $30,146
Ovarian Cancer 2010 NCI 1R41CA144818-01A1 Targeted Polymeric Combination Delivery for Treatment of Ovarian Cancer GHANDEHARI, HAMID THERATARGET UT $100,000
Ovarian Cancer 2010 NCI 1F32CA154044-01 Ruth L. Kirschstein National Research Service Awards for Individual Postdoctoral CHEUNG, ANN CALIFORNIA INSTITUTE OF TECHNOLOGY CA $47,606
Ovarian Cancer 2010 NCI 1F31CA145736-01A1 Smart Packaging: A Novel Technique for Localized Drug Delivery for Ovarian Cancer WILLIAMS, EVA CHRISTABEL UNIVERSITY OF SOUTH FLORIDA FL $30,925
Ovarian Cancer 2010 RMAP 1R01CA156695-01 Transformative personalized vascular disrupting cancer immunotherapy COUKOS, GEORGE UNIVERSITY OF PENNSYLVANIA PA $635,042
Ovarian Cancer 2010 NCI 5P01CA070970-12 0006 Cancer Stem Cells in Acute Lymphoblastic Leukemia and Ovarian Carcinoma JONES, RICHARD JOHNS HOPKINS UNIVERSITY MD $354,656
Ovarian Cancer 2010 NCI 5P30CA006516-46 9035 Core - Rapid Case Identification MUELLER, NANCY DANA-FARBER CANCER INSTITUTE MA $215,473
Ovarian Cancer 2010 NCI 3R01CA060651-18S1 Mouse Models to Study Gonadal Tumor Development MATZUK, MARTIN BAYLOR COLLEGE OF MEDICINE TX $14,690
Ovarian Cancer 2010 NCI 5P30CA014089-35 9001 Molecular and Cell Biology LANDOLPH, JOSEPH UNIVERSITY OF SOUTHERN CALIFORNIA CA $439,553
Ovarian Cancer 2010 NCI 5P30CA014089-35 9005 Transgenic/Knockout Mouse Core Facility MAXSON, ROBERT UNIVERSITY OF SOUTHERN CALIFORNIA CA $255,808
Ovarian Cancer 2010 NCI 3R21CA137686-02S1 High-throughput intracellular microrheology: a new tool for cancer research WIRTZ, DENIS JOHNS HOPKINS UNIVERSITY MD $73,239
Ovarian Cancer 2010 NCI N1CN25476A-83-0-1 Prostate, Lung, Colorectal and Ovarian (PLCO) Screening Trial O'BRIEN, BARBARA WESTAT, INC. MD $3,277,040
Ovarian Cancer 2010 NCI 5P50CA083636-12 7964 Randomized Controlled Trial Novel Markers Predict Malignancy Elevated-Risk Women URBAN, NICOLE FRED HUTCHINSON CANCER RESEARCH CENTER WA $143,955
Ovarian Cancer 2010 NCI 5P50CA083636-12 7965 Targeted Microbubble Contrast-Enhanced Ultrasound Imaging of the Ovarian Cancer V DRESCHER, CHARLES FRED HUTCHINSON CANCER RESEARCH CENTER WA $279,066
Ovarian Cancer 2010 NCI 5P50CA083636-12 7966 MicroRNA Signature of Poorly Resectable Ovarian Cancer TEWARI, MUNEESH FRED HUTCHINSON CANCER RESEARCH CENTER WA $219,457
Ovarian Cancer 2010 NCI 5P50CA083636-12 7967 Clinical Implication of the Acquisition of BRCA1/2 Function in BRCA1/2-Deflcient TANIGUCHI, TOSHIYASU FRED HUTCHINSON CANCER RESEARCH CENTER WA $273,694
Ovarian Cancer 2010 NCI 5P50CA083636-12 7968 Vaccinating against IGFBP-2 to prevent ovarian cancer relapse DISIS, MARY UNIVERSITY OF WASHINGTON WA $369,911
Ovarian Cancer 2010 NCI 5P50CA083636-12 7969 Leadership and Administration Core URBAN, NICOLE FRED HUTCHINSON CANCER RESEARCH CENTER WA $153,682
Ovarian Cancer 2010 NCI 5P50CA083636-12 7970 Clinical Specimen Management and Characterization Core KNUDSEN, BEATRICE FRED HUTCHINSON CANCER RESEARCH CENTER WA $297,940
Ovarian Cancer 2010 NCI 5P50CA083636-12 7971 Participant Recruitment, Enrollment and Characterization Core DRESCHER, CHARLES FRED HUTCHINSON CANCER RESEARCH CENTER WA $264,325
Ovarian Cancer 2010 NCI 5P50CA083636-12 7972 Biostatistics and Informatics Core MCINTOSH, MARTIN FRED HUTCHINSON CANCER RESEARCH CENTER WA $161,642
Ovarian Cancer 2010 NCI 5P50CA083636-12 7973 Developmental Research Program MCINTOSH, MARTIN FRED HUTCHINSON CANCER RESEARCH CENTER WA $68,164
Ovarian Cancer 2010 NCI 5P50CA083636-12 7974 Career and Mentoring Development Program COLLINS, STEVEN FRED HUTCHINSON CANCER RESEARCH CENTER WA $68,164
Ovarian Cancer 2010 NCI N02CN63300-5-0-4 Computer Support for Ovarian Cancer Screening in PLCO Cancer Screening Trials LAKE, WILLIAM INFORMATION MANAGEMENT SERVICES, INC. MD $381,429
Ovarian Cancer 2010 NCI 4R44CA140047-02 Cancer Progeniyor Cell Markers CHEN, WEN-TIEN VITATEX, INC. NY $702,879
Ovarian Cancer 2010 NCI 5P50CA136393-02 7923 Poisoning of PARP and Topoisomerase I to Treat Ovarian Cancer KAUFMANN, SCOTT MAYO CLINIC MN $351,800
Ovarian Cancer 2010 NCI 5P50CA136393-02 7924 Mechanisms of Immune Suppression in Ovarian Cancer KNUTSON, KEITH MAYO CLINIC MN $279,645
Ovarian Cancer 2010 NCI 5P50CA136393-02 7925 Optimizing Measles Virotherapy in the Treatment of Recurrent Ovarian Cancer GALANIS, EVANTHIA MAYO CLINIC MN $396,237
Ovarian Cancer 2010 NCI 5P50CA136393-02 7926 Flavopiridol Reverses Platinum Resistance in Ovarian Cancer BIBLE, KEITH MAYO CLINIC MN $248,246
Ovarian Cancer 2010 NCI 5P50CA136393-02 7927 Administration Core HARTMANN, LYNN MAYO CLINIC MN $206,482
Ovarian Cancer 2010 NCI 5P50CA136393-02 7928 Biospecimens/Patient Registry Core BELL, DEBRA MAYO CLINIC MN $204,180
Ovarian Cancer 2010 NCI 5P50CA136393-02 7929 Biostatistics Core OBERG, ANN MAYO CLINIC MN $218,559
Ovarian Cancer 2010 NCI 5P50CA136393-02 7930 Animal Models KNUTSON, KEITH MAYO CLINIC MN $188,653
Ovarian Cancer 2010 NCI 5P50CA136393-02 7931 Developmental Research Program KAUFMANN, SCOTT MAYO CLINIC MN $137,465
Ovarian Cancer 2010 NCI 5P50CA136393-02 7932 Career Development Program COUCH, FERGUS MAYO CLINIC MN $68,733
Ovarian Cancer 2010 NCI 5P01CA129186-04 0002 HOMOLOGY- DEPENDENT DNA REPAIR, HYPOXIA, AND CANCER THERAPY GLAZER, PETER YALE UNIVERSITY CT $321,820
Ovarian Cancer 2010 NCI 3P50CA105009-05S2 Dana-Farber/Harvard Cancer Center Ovarian Cancer SPORE CRAMER, DANIEL BRIGHAM AND WOMEN'S HOSPITAL MA $500,000
Ovarian Cancer 2010 NCI 5P50CA083638-12 7949 Gene Methylation Signatures for Predictive Classification of Response to Therapy CAIRNS, PAUL FOX CHASE CANCER CENTER PA $304,215
Ovarian Cancer 2010 NCI 5P50CA083638-12 7950 Improving the Estimation and Communication of Ovarian Cancer Risk Among BRCA1/2 C DALY, MARY FOX CHASE CANCER CENTER PA $441,569
Ovarian Cancer 2010 NCI 5P50CA083638-12 7951 Therapeutic Micro RNA Strategies for Ovarian Cancer HAMILTON, THOMAS FOX CHASE CANCER CENTER PA $522,716
Ovarian Cancer 2010 NCI 5P50CA083638-12 7952 Targeting Signaling Networks Via Novel RNAi Approaches to Improve Therapy for O GODWIN, ANDREW FOX CHASE CANCER CENTER PA $341,238
Ovarian Cancer 2010 NCI 5P50CA083638-12 7955 Advancing T cell Therapy for Ovarian Cancer COUKOS, GEORGE UNIVERSITY OF PENNSYLVANIA PA $542,075
Ovarian Cancer 2010 NCI 5P50CA083638-12 7956 Administrative Core SEIDEN, MICHAEL FOX CHASE CANCER CENTER PA $148,187
Ovarian Cancer 2010 NCI 4R00CA133190-03 Epidermal growth factor regulation of miR-125a promotes invasive ovarian cancer COWDEN DAHL, KAREN INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS IN $249,000
Ovarian Cancer 2010 NCI 5U54CA096297-08 0008 Synthesis and Pre-Clinical Evaluation of Targeted, Iron-Based MRI Contrast Agents RAPTIS, RAPHAEL UNIVERSITY OF PUERTO RICO PR $172,803
Ovarian Cancer 2010 NIAID 5P01AI068730-04 0005 COMPLEMENT IN CANCER ESTABLISHMENT AND GROWTH COUKOS, GEORGE UNIVERSITY OF PENNSYLVANIA PA $121,442
Ovarian Cancer 2010 NCI 5F31CA134188-02 Boosting therapeutic immunity against Ovarian Cancer through CD40/TLR agonists SCARLETT, UCIANE DARTMOUTH COLLEGE NH $41,380
Ovarian Cancer 2010 NCI 3R01CA127239-03S1 pBACH1 binding site on BRCT(BRCA1): A novel approach to cancer therapeutics NATARAJAN, AMARNATH UNIVERSITY OF NEBRASKA MEDICAL CENTER NE $90,477
Ovarian Cancer 2010 NCI 3R01CA115780-05A1S1 Diagnosis of Ovarian Cancer by Confocal Microendoscopy GMITRO, ARTHUR UNIVERSITY OF ARIZONA AZ $44,494
Ovarian Cancer 2010 NCI 3R01CA115483-06S1 Therapeutic Targeting Agents for Ovarian Cancer LAM, KIT UNIVERSITY OF CALIFORNIA DAVIS CA $8,892
12


  • Download Readers:
  • Download Adobe PDF Reader
  • Download Microsoft PowerPoint Viewer
  • Download Microsoft Word Viewer
  • Download Microsoft Excel Viewer